CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension Medical Therapy for CTEPH: Is There Still Space for More? Pulmonary Artery Denervation: An Alternative Therapy for Pulmonary Hypertension Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design Left main coronary artery compression in pulmonary hypertension Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial

Clinical Trial2006 Jul 4;114(1):48-54.

JOURNAL:Circulation. Article Link

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

Galiè N, Beghetti M, Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Keywords: pulmonary hypertension; invasive screening; congenital heart disease; peak oxygen uptake

FULL TEXT PDF